Norris Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-381
Closed -$294K 96
2024
Q4
$294K Sell
381
-88
-19% -$72.9K 0.14% 68
2024
Q3
$416K Buy
469
+201
+75% +$181K 0.2% 58
2024
Q2
$243K Buy
+268
New +$214K 0.13% 72

Other funds holding LLY

Norris Financial Group's LLY Position: Q1 2025 in Review

Norris Financial Group sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 381 shares — an estimated $294K sold.

Norris Financial Group first reported a position in LLY in Q2 2024 and held it in 3 quarters. The position peaked at $416K in Q3 2024. 3,927 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Norris Financial Group reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Norris Financial Group sold 381 Eli Lilly shares in Q1 2025, an estimated $294K.
  • Norris Financial Group first reported a position in Eli Lilly in Q2 2024 and held it in 3 quarters.
  • Norris Financial Group's Eli Lilly position peaked at $416K in Q3 2024.
  • 3,927 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Norris Financial Group's 13F filing for Q1 2025, filed 20 May 2026.